• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化之反思:往昔之经验与未来研究方向

Reflections on Atherosclerosis: Lesson from the Past and Future Research Directions.

作者信息

Minelli Sergio, Minelli Pierluca, Montinari Maria Rosa

机构信息

Department of Cardiology, Local Health Unit Lecce, Lecce, Italy.

Faculty of Medicine and Surgery "A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.

出版信息

J Multidiscip Healthc. 2020 Jul 17;13:621-633. doi: 10.2147/JMDH.S254016. eCollection 2020.

DOI:10.2147/JMDH.S254016
PMID:32801729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398886/
Abstract

The clinical manifestations of atherosclerosis are nowadays the main cause of death in industrialized countries, but atherosclerotic disease was found in humans who lived thousands of years ago, before the spread of current risk factors. Atherosclerotic lesions were identified on a 5300-year-old mummy, as well as in Egyptian mummies and other ancient civilizations. For many decades of the twentieth century, atherosclerosis was considered a degenerative disease, mainly determined by a passive lipid storage, while the most recent theory of atherogenesis is based on endothelial dysfunction. The importance of inflammation and immunity in atherosclerosis's pathophysiology was realized around the turn of the millennium, when in 1999 the famous pathologist Russell Ross published in the New England Journal of Medicine an article entitled "Atherosclerosis - an inflammatory disease". In the following decades, inflammation has been a topic of intense basic research in atherosclerosis, albeit its importance has ancient scientific roots. In fact, in 1856 Rudolph Virchow was the first proponent of this hypothesis, but evidence of the key role of inflammation in atherogenesis occurred only in 2017. It seemed interesting to retrace the key steps of atherosclerosis in a historical context: from the teachings of the physicians of the Roman Empire to the response-to-injury hypothesis, up to the key role of inflammation and immunity at various stages of disease. Finally, we briefly discussed current knowledge and future trajectories of atherosclerosis research and its therapeutic implications.

摘要

如今,动脉粥样硬化的临床表现是工业化国家主要的死亡原因,但在当前危险因素广泛传播之前,数千年前生活的人类身上就已发现动脉粥样硬化疾病。在一具5300年前的木乃伊以及埃及木乃伊和其他古代文明中都发现了动脉粥样硬化病变。在20世纪的几十年里,动脉粥样硬化被认为是一种退行性疾病,主要由被动脂质储存决定,而最新的动脉粥样硬化发生理论则基于内皮功能障碍。在千年之交前后,人们认识到炎症和免疫在动脉粥样硬化病理生理学中的重要性,1999年著名病理学家罗素·罗斯在《新英格兰医学杂志》上发表了一篇题为《动脉粥样硬化——一种炎症性疾病》的文章。在接下来的几十年里,炎症一直是动脉粥样硬化基础研究的热门话题,尽管其重要性有着古老的科学根源。事实上,1856年鲁道夫·魏尔啸是这一假说的首位支持者,但炎症在动脉粥样硬化发生中关键作用的证据直到2017年才出现。在历史背景下追溯动脉粥样硬化的关键步骤似乎很有意思:从罗马帝国医生的学说,到损伤应答假说,再到炎症和免疫在疾病各个阶段的关键作用。最后,我们简要讨论了动脉粥样硬化研究的当前知识和未来发展方向及其治疗意义。

相似文献

1
Reflections on Atherosclerosis: Lesson from the Past and Future Research Directions.动脉粥样硬化之反思:往昔之经验与未来研究方向
J Multidiscip Healthc. 2020 Jul 17;13:621-633. doi: 10.2147/JMDH.S254016. eCollection 2020.
2
Atherosclerosis in ancient Egyptian mummies: the Horus study.古埃及木乃伊中的动脉硬化:荷鲁斯研究。
JACC Cardiovasc Imaging. 2011 Apr;4(4):315-27. doi: 10.1016/j.jcmg.2011.02.002.
3
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
4
The discovery of the pathophysiological aspects of atherosclerosis--a review.动脉粥样硬化病理生理学方面的研究进展——综述
Acta Chir Belg. 2001 Jul-Aug;101(4):162-9.
5
Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow.从过去到现在的动脉粥样硬化研究——追寻两位观点相悖的病理学家卡尔·冯·罗基坦斯基和鲁道夫·魏尔啸的足迹。
Virchows Arch. 2006 Jul;449(1):96-103. doi: 10.1007/s00428-006-0176-7. Epub 2006 Apr 13.
6
[Some historical considerations on the inflammatory theory of atherosclerosis].[关于动脉粥样硬化炎症理论的一些历史考量]
Reumatismo. 2004 Jul-Sep;56(3):215-9. doi: 10.4081/reumatismo.2004.215.
7
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.炎症在动脉粥样硬化发病机制中的作用及治疗干预。
Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25.
8
Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE.埃及女性的动脉粥样硬化性心血管疾病:公元前 1570 年-公元 2011 年。
Int J Cardiol. 2013 Jul 31;167(2):570-4. doi: 10.1016/j.ijcard.2012.01.082. Epub 2012 Feb 20.
9
Atherosclerosis is an old disease: Summary of the Ruffer Centenary Symposium, The Paleocardiology of Ancient Egypt, a meeting report of the Horus Study team.动脉粥样硬化是一种古老的疾病:鲁弗百年研讨会纪要,古埃及心脏古生物学,荷鲁斯研究小组会议报告。
Exp Gerontol. 2011 Nov;46(11):843-6. doi: 10.1016/j.exger.2011.08.011. Epub 2011 Sep 11.
10
[Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].[动脉粥样硬化与动脉炎:对心血管疾病治疗的影响]
Herz. 2004 Feb;29(1):4-11. doi: 10.1007/s00059-004-2520-5.

引用本文的文献

1
Lipoprotein(a): Assessing the Current Knowledge and Gaps in Screening and Treatment-A Narrative Review.脂蛋白(a):评估筛查与治疗方面的现有知识及差距——一篇叙述性综述
J Cardiovasc Dev Dis. 2025 Apr 26;12(5):169. doi: 10.3390/jcdd12050169.
2
Implantable Biosensors for Vascular Diseases: Directions for the Next Generation of Active Diagnostic and Therapeutic Medical Device Technologies.用于血管疾病的可植入生物传感器:下一代主动诊断和治疗医疗设备技术的发展方向。
Biosensors (Basel). 2025 Feb 25;15(3):147. doi: 10.3390/bios15030147.
3
Cellular aspects of immunity involved in the development of atherosclerosis.

本文引用的文献

1
Macrophage subsets in atherosclerosis as defined by single-cell technologies.单细胞技术定义的动脉粥样硬化中的巨噬细胞亚群。
J Pathol. 2020 Apr;250(5):705-714. doi: 10.1002/path.5392. Epub 2020 Mar 11.
2
Neutrophils as regulators of cardiovascular inflammation.中性粒细胞作为心血管炎症的调节剂。
Nat Rev Cardiol. 2020 Jun;17(6):327-340. doi: 10.1038/s41569-019-0326-7. Epub 2020 Jan 29.
3
Opportunities for an atherosclerosis vaccine: From mice to humans.动脉粥样硬化疫苗的机遇:从老鼠到人。
动脉粥样硬化发展过程中涉及的免疫细胞方面。
Front Immunol. 2025 Jan 29;16:1461535. doi: 10.3389/fimmu.2025.1461535. eCollection 2025.
4
Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE mice.EsV3对载脂蛋白E基因敲除小鼠动脉粥样硬化病变的预防和治疗作用。
BMC Cardiovasc Disord. 2025 Jan 27;25(1):54. doi: 10.1186/s12872-025-04497-y.
5
Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review.炎症和代谢背景对缺血性中风的分子联系及临床影响:最新综述
J Clin Med. 2024 Dec 10;13(24):7515. doi: 10.3390/jcm13247515.
6
Akira Endo: Father of Statins.远藤章:他汀类药物之父。
Cureus. 2024 Aug 30;16(8):e68198. doi: 10.7759/cureus.68198. eCollection 2024 Aug.
7
Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.具有斑块破裂和中风特征的晚期冠状动脉粥样硬化新型小鼠模型
Circulation. 2024 Aug 27;150(9):706-709. doi: 10.1161/CIRCULATIONAHA.124.070464. Epub 2024 Aug 26.
8
A novel rabbit model of atherosclerotic vulnerable plaque established by cryofluid-induced endothelial injury.一种通过低温液体诱导内皮损伤建立的新型兔动脉粥样硬化易损斑块模型。
Sci Rep. 2024 Apr 24;14(1):9447. doi: 10.1038/s41598-024-60287-0.
9
Intimomedial tears of the aorta heal by smooth muscle cell-mediated fibrosis without atherosclerosis.主动脉的中膜层撕裂通过平滑肌细胞介导的纤维化愈合,而没有动脉粥样硬化。
JCI Insight. 2024 Apr 9;9(9):e172437. doi: 10.1172/jci.insight.172437.
10
Pan-vascular disease: what we have done in the past and what we can do in the future?泛血管疾病:我们过去做了什么以及未来能做什么?
Cardiol Plus. 2024 Jan-Mar;9(1):1-5. doi: 10.1097/CP9.0000000000000078. Epub 2024 Mar 8.
Vaccine. 2020 Jun 9;38(28):4495-4506. doi: 10.1016/j.vaccine.2019.12.039. Epub 2020 Jan 19.
4
Atorvastatin inhibits pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human vascular endothelial cells.阿托伐他汀通过长链非编码 RNA NEXN-AS1/NEXN 通路抑制人血管内皮细胞焦亡。
Atherosclerosis. 2020 Jan;293:26-34. doi: 10.1016/j.atherosclerosis.2019.11.033. Epub 2019 Dec 3.
5
Variable Effects Of LDL Subclasses Of Cholesterol On Endothelial Nitric Oxide/Peroxynitrite Balance - The Risks And Clinical Implications For Cardiovascular Disease.LDL 胆固醇亚类对内皮型一氧化氮/过氧亚硝酸盐平衡的可变影响——心血管疾病的风险和临床意义。
Int J Nanomedicine. 2019 Nov 18;14:8973-8987. doi: 10.2147/IJN.S223524. eCollection 2019.
6
Who's in charge here? Macrophage colony stimulating factor and granulocyte macrophage colony stimulating factor: Competing factors in macrophage polarization.这里谁负责?巨噬细胞集落刺激因子和粒细胞巨噬细胞集落刺激因子:巨噬细胞极化中的竞争因子。
Cytokine. 2020 Mar;127:154939. doi: 10.1016/j.cyto.2019.154939. Epub 2019 Nov 28.
7
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.稳定性冠心病患者低剂量秋水仙碱的疗效:LoDoCo2 试验的原理、设计和基线特征。
Am Heart J. 2019 Dec;218:46-56. doi: 10.1016/j.ahj.2019.09.011. Epub 2019 Oct 20.
8
Adaptive immunity-driven inflammation and cardiovascular disease.适应性免疫驱动的炎症与心血管疾病。
Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1254-H1257. doi: 10.1152/ajpheart.00642.2019. Epub 2019 Nov 8.
9
The Mediterranean Diet And Cardioprotection: Historical Overview And Current Research.地中海饮食与心脏保护:历史概述与当前研究
J Multidiscip Healthc. 2019 Sep 27;12:805-815. doi: 10.2147/JMDH.S219875. eCollection 2019.
10
Single-cell immune landscape of human atherosclerotic plaques.人类动脉粥样硬化斑块的单细胞免疫图谱。
Nat Med. 2019 Oct;25(10):1576-1588. doi: 10.1038/s41591-019-0590-4. Epub 2019 Oct 7.